LINDSEY CARTER: Open Payments
NPI 1225350986 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 9 payments from 7 companies in 2025. Trend: 2023 $484 · 2024 $505 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 1 | $146 |
| Amgen Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Abbott Laboratories | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Evoke, REPATHA, JOT DX, JARDIANCE, ENTRESTO, VERQUVO, LEQVIO, ELIQUIS.
Industry payments across PA — which companies pay providers there.
